Report Cover

Global Animal Model for Drug Testing Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Rats
    Mice
    Others

Segment by Application
    Academic and Research Institutes
    Pharmaceutical and Biotechnology Companies

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Charles River Laboratories
    Envigo
    Taconic Biosciences
    Jackson Laboratory
    Crown Biosciences
    Shanghai SLAC
    Shangghai Modelorg
    GenOway
    Syngene International
    Psychogenics
    Pharmaron
    Pharmalegacy
    Vitalstar Biotechnology
1 Animal Model for Drug Testing Market Overview
    1.1 Product Overview and Scope of Animal Model for Drug Testing
    1.2 Animal Model for Drug Testing Segment by Type
        1.2.1 Global Animal Model for Drug Testing Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Rats
        1.2.3 Mice
        1.2.4 Others
    1.3 Animal Model for Drug Testing Segment by Application
        1.3.1 Global Animal Model for Drug Testing Sales Comparison by Application: (2021-2027)
        1.3.2 Academic and Research Institutes
        1.3.3 Pharmaceutical and Biotechnology Companies
    1.4 Global Animal Model for Drug Testing Market Size Estimates and Forecasts
        1.4.1 Global Animal Model for Drug Testing Revenue 2016-2027
        1.4.2 Global Animal Model for Drug Testing Sales 2016-2027
        1.4.3 Animal Model for Drug Testing Market Size by Region: 2016 Versus 2021 Versus 2027

2 Animal Model for Drug Testing Market Competition by Manufacturers
    2.1 Global Animal Model for Drug Testing Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Animal Model for Drug Testing Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Animal Model for Drug Testing Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Animal Model for Drug Testing Manufacturing Sites, Area Served, Product Type
    2.5 Animal Model for Drug Testing Market Competitive Situation and Trends
        2.5.1 Animal Model for Drug Testing Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Animal Model for Drug Testing Players Market Share by Revenue
        2.5.3 Global Animal Model for Drug Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Animal Model for Drug Testing Retrospective Market Scenario by Region
    3.1 Global Animal Model for Drug Testing Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Animal Model for Drug Testing Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Animal Model for Drug Testing Market Facts & Figures by Country
        3.3.1 North America Animal Model for Drug Testing Sales by Country
        3.3.2 North America Animal Model for Drug Testing Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Animal Model for Drug Testing Market Facts & Figures by Country
        3.4.1 Europe Animal Model for Drug Testing Sales by Country
        3.4.2 Europe Animal Model for Drug Testing Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Animal Model for Drug Testing Market Facts & Figures by Region
        3.5.1 Asia Pacific Animal Model for Drug Testing Sales by Region
        3.5.2 Asia Pacific Animal Model for Drug Testing Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Animal Model for Drug Testing Market Facts & Figures by Country
        3.6.1 Latin America Animal Model for Drug Testing Sales by Country
        3.6.2 Latin America Animal Model for Drug Testing Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Animal Model for Drug Testing Market Facts & Figures by Country
        3.7.1 Middle East and Africa Animal Model for Drug Testing Sales by Country
        3.7.2 Middle East and Africa Animal Model for Drug Testing Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Animal Model for Drug Testing Historic Market Analysis by Type
    4.1 Global Animal Model for Drug Testing Sales Market Share by Type (2016-2021)
    4.2 Global Animal Model for Drug Testing Revenue Market Share by Type (2016-2021)
    4.3 Global Animal Model for Drug Testing Price by Type (2016-2021)

5 Global Animal Model for Drug Testing Historic Market Analysis by Application
    5.1 Global Animal Model for Drug Testing Sales Market Share by Application (2016-2021)
    5.2 Global Animal Model for Drug Testing Revenue Market Share by Application (2016-2021)
    5.3 Global Animal Model for Drug Testing Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Charles River Laboratories
        6.1.1 Charles River Laboratories Corporation Information
        6.1.2 Charles River Laboratories Description and Business Overview
        6.1.3 Charles River Laboratories Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Charles River Laboratories Animal Model for Drug Testing Product Portfolio
        6.1.5 Charles River Laboratories Recent Developments/Updates
    6.2 Envigo
        6.2.1 Envigo Corporation Information
        6.2.2 Envigo Description and Business Overview
        6.2.3 Envigo Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Envigo Animal Model for Drug Testing Product Portfolio
        6.2.5 Envigo Recent Developments/Updates
    6.3 Taconic Biosciences
        6.3.1 Taconic Biosciences Corporation Information
        6.3.2 Taconic Biosciences Description and Business Overview
        6.3.3 Taconic Biosciences Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Taconic Biosciences Animal Model for Drug Testing Product Portfolio
        6.3.5 Taconic Biosciences Recent Developments/Updates
    6.4 Jackson Laboratory
        6.4.1 Jackson Laboratory Corporation Information
        6.4.2 Jackson Laboratory Description and Business Overview
        6.4.3 Jackson Laboratory Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Jackson Laboratory Animal Model for Drug Testing Product Portfolio
        6.4.5 Jackson Laboratory Recent Developments/Updates
    6.5 Crown Biosciences
        6.5.1 Crown Biosciences Corporation Information
        6.5.2 Crown Biosciences Description and Business Overview
        6.5.3 Crown Biosciences Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Crown Biosciences Animal Model for Drug Testing Product Portfolio
        6.5.5 Crown Biosciences Recent Developments/Updates
    6.6 Shanghai SLAC
        6.6.1 Shanghai SLAC Corporation Information
        6.6.2 Shanghai SLAC Description and Business Overview
        6.6.3 Shanghai SLAC Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Shanghai SLAC Animal Model for Drug Testing Product Portfolio
        6.6.5 Shanghai SLAC Recent Developments/Updates
    6.7 Shangghai Modelorg
        6.6.1 Shangghai Modelorg Corporation Information
        6.6.2 Shangghai Modelorg Description and Business Overview
        6.6.3 Shangghai Modelorg Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Shangghai Modelorg Animal Model for Drug Testing Product Portfolio
        6.7.5 Shangghai Modelorg Recent Developments/Updates
    6.8 GenOway
        6.8.1 GenOway Corporation Information
        6.8.2 GenOway Description and Business Overview
        6.8.3 GenOway Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 GenOway Animal Model for Drug Testing Product Portfolio
        6.8.5 GenOway Recent Developments/Updates
    6.9 Syngene International
        6.9.1 Syngene International Corporation Information
        6.9.2 Syngene International Description and Business Overview
        6.9.3 Syngene International Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Syngene International Animal Model for Drug Testing Product Portfolio
        6.9.5 Syngene International Recent Developments/Updates
    6.10 Psychogenics
        6.10.1 Psychogenics Corporation Information
        6.10.2 Psychogenics Description and Business Overview
        6.10.3 Psychogenics Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Psychogenics Animal Model for Drug Testing Product Portfolio
        6.10.5 Psychogenics Recent Developments/Updates
    6.11 Pharmaron
        6.11.1 Pharmaron Corporation Information
        6.11.2 Pharmaron Animal Model for Drug Testing Description and Business Overview
        6.11.3 Pharmaron Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Pharmaron Animal Model for Drug Testing Product Portfolio
        6.11.5 Pharmaron Recent Developments/Updates
    6.12 Pharmalegacy
        6.12.1 Pharmalegacy Corporation Information
        6.12.2 Pharmalegacy Animal Model for Drug Testing Description and Business Overview
        6.12.3 Pharmalegacy Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Pharmalegacy Animal Model for Drug Testing Product Portfolio
        6.12.5 Pharmalegacy Recent Developments/Updates
    6.13 Vitalstar Biotechnology
        6.13.1 Vitalstar Biotechnology Corporation Information
        6.13.2 Vitalstar Biotechnology Animal Model for Drug Testing Description and Business Overview
        6.13.3 Vitalstar Biotechnology Animal Model for Drug Testing Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Vitalstar Biotechnology Animal Model for Drug Testing Product Portfolio
        6.13.5 Vitalstar Biotechnology Recent Developments/Updates

7 Animal Model for Drug Testing Manufacturing Cost Analysis
    7.1 Animal Model for Drug Testing Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Animal Model for Drug Testing
    7.4 Animal Model for Drug Testing Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Animal Model for Drug Testing Distributors List
    8.3 Animal Model for Drug Testing Customers

9 Animal Model for Drug Testing Market Dynamics
    9.1 Animal Model for Drug Testing Industry Trends
    9.2 Animal Model for Drug Testing Growth Drivers
    9.3 Animal Model for Drug Testing Market Challenges
    9.4 Animal Model for Drug Testing Market Restraints

10 Global Market Forecast
    10.1 Animal Model for Drug Testing Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Animal Model for Drug Testing by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Animal Model for Drug Testing by Type (2022-2027)
    10.2 Animal Model for Drug Testing Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Animal Model for Drug Testing by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Animal Model for Drug Testing by Application (2022-2027)
    10.3 Animal Model for Drug Testing Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Animal Model for Drug Testing by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Animal Model for Drug Testing by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Animal Model for Drug Testing Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Animal Model for Drug Testing Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Animal Model for Drug Testing Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Animal Model for Drug Testing Covered in This Study Table 5. Global Animal Model for Drug Testing Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Animal Model for Drug Testing Sales Market Share by Manufacturers (2016-2021) Table 7. Global Animal Model for Drug Testing Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Animal Model for Drug Testing Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Animal Model for Drug Testing Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Animal Model for Drug Testing Manufacturing Sites and Area Served Table 11. Manufacturers Animal Model for Drug Testing Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Animal Model for Drug Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Model for Drug Testing as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Animal Model for Drug Testing Sales by Region (2016-2021) & (K Units) Table 16. Global Animal Model for Drug Testing Sales Market Share by Region (2016-2021) Table 17. Global Animal Model for Drug Testing Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Animal Model for Drug Testing Sales by Country (2016-2021) & (K Units) Table 19. North America Animal Model for Drug Testing Sales Market Share by Country (2016-2021) Table 20. North America Animal Model for Drug Testing Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Animal Model for Drug Testing Revenue Market Share by Country (2016-2021) Table 22. Europe Animal Model for Drug Testing Sales by Country (2016-2021) & (K Units) Table 23. Europe Animal Model for Drug Testing Sales Market Share by Country (2016-2021) Table 24. Europe Animal Model for Drug Testing Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Animal Model for Drug Testing Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Animal Model for Drug Testing Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Animal Model for Drug Testing Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Animal Model for Drug Testing Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Animal Model for Drug Testing Revenue Market Share by Region (2016-2021) Table 30. Latin America Animal Model for Drug Testing Sales by Country (2016-2021) & (K Units) Table 31. Latin America Animal Model for Drug Testing Sales Market Share by Country (2016-2021) Table 32. Latin America Animal Model for Drug Testing Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Animal Model for Drug Testing Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Animal Model for Drug Testing Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Animal Model for Drug Testing Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Animal Model for Drug Testing Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Animal Model for Drug Testing Revenue Market Share by Country (2016-2021) Table 38. Global Animal Model for Drug Testing Sales (K Units) by Type (2016-2021) Table 39. Global Animal Model for Drug Testing Sales Market Share by Type (2016-2021) Table 40. Global Animal Model for Drug Testing Revenue (Million US$) by Type (2016-2021) Table 41. Global Animal Model for Drug Testing Revenue Share by Type (2016-2021) Table 42. Global Animal Model for Drug Testing Price (US$/Unit) by Type (2016-2021) Table 43. Global Animal Model for Drug Testing Sales (K Units) by Application (2016-2021) Table 44. Global Animal Model for Drug Testing Sales Market Share by Application (2016-2021) Table 45. Global Animal Model for Drug Testing Revenue (Million US$) by Application (2016-2021) Table 46. Global Animal Model for Drug Testing Revenue Share by Application (2016-2021) Table 47. Global Animal Model for Drug Testing Price (US$/Unit) by Application (2016-2021) Table 48. Charles River Laboratories Corporation Information Table 49. Charles River Laboratories Description and Business Overview Table 50. Charles River Laboratories Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Charles River Laboratories Animal Model for Drug Testing Product Table 52. Charles River Laboratories Recent Developments/Updates Table 53. Envigo Corporation Information Table 54. Envigo Description and Business Overview Table 55. Envigo Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Envigo Animal Model for Drug Testing Product Table 57. Envigo Recent Developments/Updates Table 58. Taconic Biosciences Corporation Information Table 59. Taconic Biosciences Description and Business Overview Table 60. Taconic Biosciences Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Taconic Biosciences Animal Model for Drug Testing Product Table 62. Taconic Biosciences Recent Developments/Updates Table 63. Jackson Laboratory Corporation Information Table 64. Jackson Laboratory Description and Business Overview Table 65. Jackson Laboratory Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Jackson Laboratory Animal Model for Drug Testing Product Table 67. Jackson Laboratory Recent Developments/Updates Table 68. Crown Biosciences Corporation Information Table 69. Crown Biosciences Description and Business Overview Table 70. Crown Biosciences Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Crown Biosciences Animal Model for Drug Testing Product Table 72. Crown Biosciences Recent Developments/Updates Table 73. Shanghai SLAC Corporation Information Table 74. Shanghai SLAC Description and Business Overview Table 75. Shanghai SLAC Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Shanghai SLAC Animal Model for Drug Testing Product Table 77. Shanghai SLAC Recent Developments/Updates Table 78. Shangghai Modelorg Corporation Information Table 79. Shangghai Modelorg Description and Business Overview Table 80. Shangghai Modelorg Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Shangghai Modelorg Animal Model for Drug Testing Product Table 82. Shangghai Modelorg Recent Developments/Updates Table 83. GenOway Corporation Information Table 84. GenOway Description and Business Overview Table 85. GenOway Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. GenOway Animal Model for Drug Testing Product Table 87. GenOway Recent Developments/Updates Table 88. Syngene International Corporation Information Table 89. Syngene International Description and Business Overview Table 90. Syngene International Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Syngene International Animal Model for Drug Testing Product Table 92. Syngene International Recent Developments/Updates Table 93. Psychogenics Corporation Information Table 94. Psychogenics Description and Business Overview Table 95. Psychogenics Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Psychogenics Animal Model for Drug Testing Product Table 97. Psychogenics Recent Developments/Updates Table 98. Pharmaron Corporation Information Table 99. Pharmaron Description and Business Overview Table 100. Pharmaron Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Pharmaron Animal Model for Drug Testing Product Table 102. Pharmaron Recent Developments/Updates Table 103. Pharmalegacy Corporation Information Table 104. Pharmalegacy Description and Business Overview Table 105. Pharmalegacy Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Pharmalegacy Animal Model for Drug Testing Product Table 107. Pharmalegacy Recent Developments/Updates Table 108. Vitalstar Biotechnology Corporation Information Table 109. Vitalstar Biotechnology Description and Business Overview Table 110. Vitalstar Biotechnology Animal Model for Drug Testing Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Vitalstar Biotechnology Animal Model for Drug Testing Product Table 112. Vitalstar Biotechnology Recent Developments/Updates Table 113. Production Base and Market Concentration Rate of Raw Material Table 114. Key Suppliers of Raw Materials Table 115. Animal Model for Drug Testing Distributors List Table 116. Animal Model for Drug Testing Customers List Table 117. Animal Model for Drug Testing Market Trends Table 118. Animal Model for Drug Testing Growth Drivers Table 119. Animal Model for Drug Testing Market Challenges Table 120. Animal Model for Drug Testing Market Restraints Table 121. Global Animal Model for Drug Testing Sales Forecast by Type (2022-2027) & (K Units) Table 122. Global Animal Model for Drug Testing Sales Market Share Forecast by Type (2022-2027) Table 123. Global Animal Model for Drug Testing Revenue Forecast by Type (2022-2027) & (US$ Million) Table 124. Global Animal Model for Drug Testing Revenue Market Share Forecast by Type (2022-2027) Table 125. Global Animal Model for Drug Testing Sales Forecast by Application (2022-2027) & (K Units) Table 126. Global Animal Model for Drug Testing Sales Market Share Forecast by Application (2022-2027) Table 127. Global Animal Model for Drug Testing Revenue Forecast by Application (2022-2027) & (US$ Million) Table 128. Global Animal Model for Drug Testing Revenue Market Share Forecast by Application (2022-2027) Table 129. Global Animal Model for Drug Testing Sales Forecast by Region (2022-2027) & (K Units) Table 130. Global Animal Model for Drug Testing Sales Market Share Forecast by Region (2022-2027) Table 131. Global Animal Model for Drug Testing Revenue Forecast by Region (2022-2027) & (US$ Million) Table 132. Global Animal Model for Drug Testing Revenue Market Share Forecast by Region (2022-2027) Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Animal Model for Drug Testing Figure 2. Global Animal Model for Drug Testing Market Share by Type in 2020 & 2027 Figure 3. Rats Product Picture Figure 4. Mice Product Picture Figure 5. Others Product Picture Figure 6. Global Animal Model for Drug Testing Market Share by Application in 2020 & 2027 Figure 7. Academic and Research Institutes Figure 8. Pharmaceutical and Biotechnology Companies Figure 9. Global Animal Model for Drug Testing Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Animal Model for Drug Testing Market Size 2016-2027 (US$ Million) Figure 11. Global Animal Model for Drug Testing Sales 2016-2027 (K Units) Figure 12. Global Animal Model for Drug Testing Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Animal Model for Drug Testing Sales Share by Manufacturers in 2020 Figure 14. Global Animal Model for Drug Testing Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Animal Model for Drug Testing Players: Market Share by Revenue in 2020 Figure 16. Animal Model for Drug Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Animal Model for Drug Testing Sales Market Share by Region (2016-2021) Figure 18. Global Animal Model for Drug Testing Sales Market Share by Region in 2020 Figure 19. Global Animal Model for Drug Testing Revenue Market Share by Region (2016-2021) Figure 20. Global Animal Model for Drug Testing Revenue Market Share by Region in 2020 Figure 21. United States Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Taiwan Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Mexico Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Brazil Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Argentina Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Turkey Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Saudi Arabia Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. UAE Animal Model for Drug Testing Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Sales Market Share of Animal Model for Drug Testing by Type (2016-2021) Figure 44. Sales Market Share of Animal Model for Drug Testing by Application (2016-2021) Figure 45. Sales Market Share of Animal Model for Drug Testing by Application in 2020 Figure 46. Revenue Share of Animal Model for Drug Testing by Application (2016-2021) Figure 47. Revenue Share of Animal Model for Drug Testing by Application in 2020 Figure 48. Manufacturing Cost Structure of Animal Model for Drug Testing Figure 49. Manufacturing Process Analysis of Animal Model for Drug Testing Figure 50. Animal Model for Drug Testing Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us